Orthopediatrics Corp (KIDS) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Orthopediatrics reported revenue of $236.3M, up 15.4% from $204.7M the year before. Net income was -$39.6M (a -16.8% net margin), or -$1.69 per diluted share. Gross margin was 73.1% and operating margin was -16.6%. Operating activities generated -$4.9M of cash, leaving -$16.0M of free cash flow. At fiscal year end, Orthopediatrics held $508.6M in total assets against $162.0M in total liabilities, including $19.6M of cash and equivalents.
Open the full interactive Orthopediatrics financials → Quarterly statements, key ratios, valuation history and price charts.
Orthopediatrics Key Stats
| Share Price | $21.93 |
|---|---|
| Market Cap | $527.4M |
| Revenue YoY Growth | +15.4% |
| 52-Week Range | $14.64 – $26.50 |
| Shares Outstanding | 24.0 million (basic, 2026 Q2) |
Orthopediatrics Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $71.1M | $98.0M | $122.3M | $148.7M | $204.7M | $236.3M |
| Cost of Goods Sold | $16.0M | $24.6M | $31.6M | $37.5M | $56.1M | $63.7M |
| Gross Profit | $55.0M | $73.4M | $90.7M | $111.3M | $148.6M | $172.7M |
| Operating Income | -$26.8M | -$18.0M | -$25.4M | -$26.8M | -$35.0M | -$39.2M |
| Pre-Tax Income | -$33.7M | -$17.4M | -$3.7M | -$21.3M | -$41.9M | -$39.2M |
| Income Tax | -$723,000 | -$1.1M | -$4.9M | -$338,000 | -$4.1M | $460,000 |
| Net Income | -$32.9M | -$16.3M | $1.3M | -$21.0M | -$37.8M | -$39.6M |
| Diluted EPS | -$1.82 | -$0.84 | $0.06 | -$0.92 | -$1.64 | -$1.69 |
Orthopediatrics Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $61.2M | $61.6M | $59.4M | $70.5M |
| Net Income | -$11.8M | -$10.1M | -$10.7M | -$7.2M |
| Diluted EPS | -$0.50 | -$0.43 | -$0.45 | -$0.30 |
Orthopediatrics Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $28.8M | $7.6M | — | $31.1M | $43.8M | $19.6M |
| Current Assets | $158.4M | $133.6M | $226.7M | $226.5M | $237.2M | $256.4M |
| Total Assets | $320.4M | $304.3M | $427.7M | $438.7M | $473.2M | $508.6M |
| Current Liabilities | $35.0M | $29.7M | $30.9M | $41.7M | $34.0M | $46.2M |
| Total Long-Term Debt | $1.2M | $1.0M | $907,000 | $10.1M | $73.9M | $101.7M |
| Total Liabilities | $85.6M | $78.9M | $49.1M | $61.7M | $118.6M | $162.0M |
| Shareholders' Equity | $234.8M | $225.4M | $378.6M | $377.0M | $354.6M | $346.6M |
Orthopediatrics Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$18.5M | -$13.1M | -$21.8M | -$27.0M | -$27.0M | -$4.9M |
| Cash From Investing | -$69.7M | -$7.4M | -$113.4M | $41.7M | -$13.2M | -$43.6M |
| Cash From Financing | $46.7M | $6,000 | $136.0M | $7.3M | $53.1M | $24.0M |
| Free Cash Flow | -$29.0M | -$21.2M | -$31.8M | -$43.9M | -$41.3M | -$16.0M |
Figures from Orthopediatrics' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Orthopediatrics financials page for every line item.
Orthopediatrics Company Profile
| Ticker | KIDS |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Warsaw, Indiana |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001425450 |
Frequently Asked Questions
What was Orthopediatrics' revenue in fiscal 2025?
Orthopediatrics (KIDS) reported revenue of $236.3M for fiscal 2025.
What is Orthopediatrics' annual revenue history?
Orthopediatrics' annual revenue by fiscal year: 2020: $71.1M; 2021: $98.0M; 2022: $122.3M; 2023: $148.7M; 2024: $204.7M; 2025: $236.3M.
What was Orthopediatrics' net income in fiscal 2025?
Orthopediatrics reported net income of -$39.6M for fiscal 2025.
What was Orthopediatrics' earnings per share (EPS) in fiscal 2025?
Orthopediatrics' diluted EPS was -$1.69 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Orthopediatrics generate in fiscal 2025?
Orthopediatrics generated -$16.0M of free cash flow in fiscal 2025.
What was Orthopediatrics' revenue last quarter?
In its most recent reported quarter (2026 Q2), Orthopediatrics reported revenue of $70.5M.
How much debt does Orthopediatrics have?
Orthopediatrics reported $101.7M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Orthopediatrics are outstanding?
Orthopediatrics reported a weighted average of 24.0 million basic shares outstanding in 2026 Q2.
What is Orthopediatrics' market cap?
Based on its latest closing price, Orthopediatrics (KIDS) has a market capitalization of about $527.4M.
When does Orthopediatrics' fiscal year end?
Orthopediatrics' fiscal year end, as registered with the SEC, is December 31.
Where is Orthopediatrics headquartered?
Orthopediatrics lists its business address in Warsaw, Indiana in its SEC filings.
Orthopediatrics Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →